Molbio Diagnostics IPO

Molecular Diagnostics (Point-of-Care Testing) - Listed on 17 August 2026

+21.4% listing gain
Issue Price (Upper)
Rs 807
Listing Price
Rs 980
Closing Price (NSE)
Rs 1,041.7
Total Subscription
70.26x

Molbio Diagnostics IPO listing summary

Molbio Diagnostics (Molecular Diagnostics (Point-of-Care Testing)) closed its IPO window in 2026 and listed on NSE and BSE on 17 August 2026 at an upper band issue price of Rs 807, opening at Rs 980 for a listing gain of +21.4% and closing day one at Rs 1041.7 (+29.1% on closing basis). The IPO was subscribed 70.26x overall - QIB 186.39x, HNI/NII 49.80x, Retail 12.96x. The total issue size was Rs 939.7 Cr (Fresh Issue Rs 200.16 Cr, OFS Rs 739.7 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+21.44%
Listing Gain (Close)
+29.09%
Day Change After Listing
+6.30%
Retail Quota
35.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB186.39x
HNI / NII49.80x
Retail12.96x
Overall70.26x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 10.83x
Day 23.11x
Day 3 (Final)70.26x

Molbio Diagnostics IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 220+21.06%
Day 2Rs 170+21.06%
Day 3Rs 137+17.00%
Day 4Rs 133+16.11%
Day 5Rs 150+20.45%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
16.1%-21.1%
IPOGyani AI Prediction
22.3%
Actual Listing Gain
+21.4%

Prediction Accuracy: 0.9 pp (Highly accurate)

Issue & financials

Issue SizeRs 939.7 Cr
Fresh IssueRs 200.16 Cr
OFSRs 739.7 Cr
IPO PE55.84
Peer / Sector PE54.64
PE vs Sector Ratio1.02
Latest EBITDA (Cr)22.56
Debt / Equity0.07

Market context at listing

How the broader market moved around the Molbio Diagnostics IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return-
Nifty 1W Return-
Nifty 1M Return-
Nifty during IPO window-

Molbio Diagnostics IPO - FAQs

What was the listing gain of Molbio Diagnostics IPO?

Molbio Diagnostics IPO listed at +21.4% versus the upper issue price of Rs 807 on 17 August 2026.

How many times was Molbio Diagnostics IPO subscribed?

Molbio Diagnostics IPO was subscribed 70.26x overall. QIB portion was subscribed 186.39x, HNI / NII 49.80x and Retail 12.96x.

What was the IPO GMP for Molbio Diagnostics?

IPO GMP started at Rs 220 on Day 1 and moved to Rs 150 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2026

Browse listed IPOs by year